SCHEMBL5697694

SCHEMBL5697694

ClOc1ccc(CN2CCOCC2)cn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 5/20 0.56
SMN1; SMN2 Q16637 3/20 0.53
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
MAPT P10636 1/20 0.49
KCNJ1 P48048 1/20 0.49
HIF1A Q16665 3/20 0.46
EPAS1 Q99814 3/20 0.46
MEN1 O00255 1/20 0.46
NPC1 O15118 1/20 0.46
TP53 P04637 1/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
CHEK1 O14757 1/20 0.44
NOS3 P29474 1/20 0.43
NOS1 P29475 1/20 0.43
NOS2 P35228 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27899079 0.85 SMN1; SMN2 (0.60) HRH3SMN1; SMN2MEN1NPC1TP53
SCHEMBL5697707 0.84 HRH3 (0.67) HRH3SMN1; SMN2ALDH1A1TSHR
SCHEMBL392531 0.80 HRH3 (0.61) HRH3SMN1; SMN2HIF1AEPAS1MEN1
SCHEMBL15467001 0.78 HRH3 (0.87) HRH3SMN1; SMN2ALDH1A1LMNAMAPT
SCHEMBL1820767 0.78 HRH3 (0.58) HRH3SMN1; SMN2ALDH1A1LMNAMAPT
SCHEMBL1865018 0.77 HRH3 (0.85) HRH3
SCHEMBL23235216 0.76 HRH3 (0.56) HRH3SMN1; SMN2ALDH1A1LMNAMAPT
SCHEMBL115530 0.76 DRD2 (0.56) HRH3SMN1; SMN2ALDH1A1LMNAMAPT
SCHEMBL1822660 0.76 HRH3 (0.56) HRH3SMN1; SMN2ALDH1A1LMNAMAPT
SCHEMBL1820769 0.76 HRH3 (0.56) HRH3SMN1; SMN2ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1667990-A2 NEW COMPOUNDS AstraZeneca AB (SE) 2006-06-14 EP claimed
WO-2005027823-A2 3-HETEROCYCLYL-INDOLE DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE KINASE-3 (GSK-3) ASTRAZENECA AB (SE) 2005-03-31 WO claimed
EP-1667990-A2 NEW COMPOUNDS AstraZeneca AB (SE) 2006-06-14 EP disclosed
WO-2005027823-A2 3-HETEROCYCLYL-INDOLE DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE KINASE-3 (GSK-3) ASTRAZENECA AB (SE) 2005-03-31 WO disclosed